InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
P2P
0.00%
4.4¢
P2P TRANSPORT LIMITED
Currently unlisted.
Proposed listing date: 11.00 AM AEDST 13 DECEMBER 2017
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
P2P | News: P2P P2P Transport Posts HY Net Loss Attributable Of $2.6 Mln | 11/03/19 | 1 | 1.0K | |||
|
|||||||
P2P | Ann: Cleansing Notice - Convertible Notes | 28/02/19 | 0 | 279 | |||
|
|||||||
P2P | Ann: Appendix 3B - Convertible Notes and Shares | 28/02/19 | 0 | 127 | |||
|
|||||||
P2P | Ann: Cleansing Notice -Share Issue | 28/02/19 | 0 | 101 | |||
|
|||||||
P2P | Ann: 2019 Half Year Results Presentation | 28/02/19 | 0 | 92 | |||
|
|||||||
P2P | Ann: H1 FY2019 Half Year Results Announcement | 28/02/19 | 0 | 54 | |||
|
|||||||
P2P | Ann: Appendix 4D and Half Year Report 31 December 2018 | 28/02/19 | 0 | 53 | |||
|
|||||||
P2P | Ann: Acquisition and Capital Facility Completed | 26/02/19 | 3 | 1.6K | |||
|
See All Discussions